Bilateral Hand Swelling: Diagnostic Approach and Management

Introduction to Bilateral Hand Swelling

Bilateral hand swelling suggests systemic causes, including inflammatory arthritis, drug toxicity, endocrine disorders, or systemic vascular processes, according to the American College of Rheumatology 1, 2

Erosive hand osteoarthritis targets interphalangeal joints with inflammatory symptoms, including soft tissue swelling, erythema, paresthesias, and mildly elevated inflammatory markers, as noted by the American College of Rheumatology 2
Psoriatic arthritis causes painful, swollen joints with characteristic dactylitis, affecting hands and feet, according to the National Psoriasis Foundation 2
Scleroderma presents with hand swelling, Raynaud's phenomenon, and may be associated with pulmonary hypertension, as reported by the Scleroderma Foundation 2

Chemotherapy-induced hand-foot syndrome causes redness, discomfort, swelling, and tingling in palms and soles, occurring with certain chemotherapy agents, as described by the American Society of Clinical Oncology 5
Targeted therapy-induced hand-foot skin reaction from BRAF inhibitors and multikinase VEGFR inhibitors causes painful hyperkeratosis on pressure areas, according to the National Comprehensive Cancer Network 5

Increased capillary hydrostatic pressure from superior vena cava syndrome, bilateral DVT, or reflex sympathetic dystrophy can cause bilateral hand swelling, as noted by the American Heart Association 2
Increased capillary permeability from systemic allergic reactions, widespread infection, or systemic inflammatory states can also contribute to bilateral hand swelling, according to the American College of Allergy, Asthma, and Immunology 2

Determine medication history, specifically asking about chemotherapy agents, as drug-induced causes are common and treatment-modifiable, as recommended by the American Society of Clinical Oncology 5
Evaluate for rheumatologic symptoms, including morning stiffness, joint pain pattern, Raynaud's phenomenon, skin tightening, and rashes, according to the American College of Rheumatology 2

Rheumatoid factor, anti-CCP antibodies, ANA, ESR/CRP for inflammatory arthritis, as recommended by the American College of Rheumatology 2
Thyroid function tests if thyroid disease is suspected, according to the American Thyroid Association 4

Plain radiographs in two planes are mandatory for any musculoskeletal pathology with swelling, as noted by the American College of Radiology 1
Duplex ultrasound to exclude bilateral upper extremity DVT if vascular obstruction is suspected, according to the American Heart Association 1, 3

Grade 1-2: Continue drug at current dose; initiate oral tetracycline and topical low/moderate steroid; reassess after 2 weeks, as recommended by the American Society of Clinical Oncology 5
Grade ≥3 or intolerable Grade 2: Interrupt drug until Grade 0-1; continue oral antibiotic and topical steroid; add systemic corticosteroids, according to the National Comprehensive Cancer Network 5

Refer to rheumatology for disease-modifying therapy based on specific diagnosis, as recommended by the American College of Rheumatology 2
NSAIDs for mild-moderate pain, according to the American College of Rheumatology 3

Do not assume bilateral swelling is benign edema—it requires systematic evaluation for underlying systemic disease, as noted by the American College of Rheumatology 1, 2
Do not empirically treat as cellulitis without considering drug-induced causes, especially in patients on chemotherapy, according to the American Society of Clinical Oncology 5

Reassess within 48-72 hours to evaluate response to initial management and ensure no progression, as recommended by the American College of Rheumatology 3, 2
Schedule formal evaluation at 6 weeks if edema persists to detect delayed complications or underlying pathology, according to the American College of Rheumatology 1, 3, 2